People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Other Health Care, Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Headlands Research, Inc. | — | Other Health Care | Series A | $29.2M | $4.5M | 2019 |
| Datacubed Health, Inc. | — | Healthtech | Series A | $22.4M | $52.5M | 2023 |
| Cnsbio Inc | — | Biotechnology | Series A | $9.1M | $27.1M | 2009 |
Mark Blumling at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Blumling on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ali Satvat | 1 | 4 |
| Steven Taslitz | 1 | 3 |
| Matthew Morgan | 1 | 3 |
| Olympia De Castro | 1 | 2 |
| Cathy Collins | 1 | 2 |
| Neel Varshney | 1 | 2 |
| Autumn Huiatt | 1 | 1 |
| Kathy Collins | 1 | 1 |
| Heather Abbis | 1 | 1 |
| Emily Janvey | 1 | 1 |
| Laurie Holloran | 1 | 1 |
| Kyle Hogan | 1 | 1 |
| Marie Onakomaiya | 1 | 1 |
| Chiang Ying Yi | 1 | 1 |
| Ariana Mavaddat | 1 | 1 |
| Brett Kleger | 1 | 1 |
| Olympia DeCastro | 1 | 1 |
| Nicholas Cortezi | 1 | 1 |
| Laurie Halloran | 1 | 1 |
| Paul Glimcher | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.